Lee Hodge

Lee is a co-founder of qPharmetra and is currently CFO. Lee has applied Pharmacometrics to solve drug development problems for 14 years. He has either taken part or led many analysis, and has a special focus on Rheumatoid Arthritis and Oncology. Lee’s interests are primarily on analyses that inform strategic, internal decision-making, such as calculating the value of information from Proof of Concept trials, predicting clinical efficacy given early results to guide decisions on Phase III, and informing post-marketing decisions. These reflect his advanced training, years of experience, and affinity for Decision Analysis.